The Latest Cardiac and Vascular News
Company expands leadership team ahead of first US product launch Prairie Village, KS – July 14, 2021 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced the hiring of Erdie De Peralta as Vice President of Clinical […]
Fiscal 2021 Fourth Quarter Highlights Net sales of $76.8 million increased 31.7% compared to the prior-year quarter Gross margin of 55.1% increased 330 basis points year over year GAAP loss per share of $0.51, inclusive of a $14.0 million write-off of OARTrac intangible assets, and adjusted earnings per share of […]
Novel 3-in-1 system provides predictable left atrium access to support transseptal interventions MIAMI, July 13, 2021 /PRNewswire/ — East End Medical, a private medical device company committed to improving catheter-based cardiac procedures, today announced it received U.S. Food and Drug Administration (FDA) clearance for the company’s SafeCross™ Transseptal Radiofrequency (RF) Puncture & Steerable Balloon […]
EurekaAI helps predict heart attacks through AI analysis of patient data LOS ALTOS, Calif., July 13, 2021 /PRNewswire/ — SymphonyAI, a leader in high-value enterprise AI solutions for key vertical sectors, announced today the expansion of a partnership with Semmelweis University Heart and Vascular Center, a leading research institution in East-Central Europe. […]
Texas installation builds as company adds team members to support installations around major metropolitan areas Westport, CT, July 13, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the […]
CARLSBAD, Calif., July 12, 2021 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported preliminary unaudited results for the second quarter of 2021. Recent Highlights and Upcoming Events: Preliminary net […]
Neovasc Team Grows with Addition of Industry Veterans Lisa Becker as VP, Regulatory Affairs, Global Angina Therapies and Sarah Gallagher as VP of Clinical Affairs VANCOUVER and MINNEAPOLIS, July 13, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq, TSX: NVCN) announced today that it has appointed Lisa Becker […]
Highly specific HDAC6 inhibitors (HDAC6i) demonstrated improved cardiac function in mouse models of heart failure with preserved ejection in fraction (HFpEF) and genetic dilated cardiomyopathy (gDCM) Potential utility of HDAC6 as a target in heart disease was validated using Tenaya’s Precision Medicine platform HDAC6i product candidate TYA-11631 is currently in IND-enabling […]
The company continues to expand its global business, launching multiple products in the United States and internationally in 2021 YOKNEAM, Israel–(BUSINESS WIRE)–Rapid Medical, a company focused on the development of responsive, adjustable neurovascular devices, announced today that Daniel Levangie has been appointed to its Board of Directors. “We are thrilled to welcome […]
CARLSBAD, Calif., July 12, 2021 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB) today announced it has commenced an underwritten public offering of 5,500,000 shares of its common stock. All of the shares of common stock are being offered by Acutus. In addition, Acutus expects to […]
